Ann Oncol: Most-Cited Full-Text Articles http://annonc.oxfordjournals.org/ Most-cited rankings are recalculated at the beginning of the month and are based on citations to articles on this journal site from articles in other HighWire-hosted journals. 2009-11-14 <![CDATA[Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005]]> http://annonc.oxfordjournals.org/cgi/content/short/16/10/1569?rss=1&ssource=mfc Oct 1, 2005; 16:1569-1583
Reviews]]> A. Goldhirsch, J. H. Glick, R. D. Gelber, A. S. Coates, B. Thurlimann, H.-J. Senn, and Panel Members 2005-10-01 Oxford University Press <![CDATA[Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007]]> http://annonc.oxfordjournals.org/cgi/content/short/18/7/1133?rss=1&ssource=mfc Jul 1, 2007; 18:1133-1144
]]> A. Goldhirsch, W. C. Wood, R. D. Gelber, A. S. Coates, B. Thurlimann, H. -J. Senn, Panel Members 2007-07-01 10.1093/annonc/mdm271 Oxford University Press <![CDATA[Cancer incidence and mortality in Europe, 2004]]> http://annonc.oxfordjournals.org/cgi/content/short/16/3/481?rss=1&ssource=mfc Mar 1, 2005; 16:481-488
Epidemiology]]> P. Boyle, J. Ferlay 2005-03-01 Oxford University Press <![CDATA[Estimates of the cancer incidence and mortality in Europe in 2006]]> http://annonc.oxfordjournals.org/cgi/content/short/18/3/581?rss=1&ssource=mfc Mar 1, 2007; 18:581-592
]]> J Ferlay, P Autier, M Boniol, M Heanue, M Colombet, P Boyle 2007-03-01 Oxford University Press <![CDATA[A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/7/4/347?rss=1&ssource=mfc Apr 1, 1996; 7:347-353
]]> M. L. Rothenberg, M. J. Moore, M. C. Cripps, J. S. Andersen, R. K. Portenoy, H. A. Burriss III, M. R. Green, P. G. Tarassoff, T. D. Brown, E. S. Casper, A.-M. Storniolo, D. D. Von Hoff 1996-04-01 Oxford University Press <![CDATA[KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab]]> http://annonc.oxfordjournals.org/cgi/content/short/19/3/508?rss=1&ssource=mfc Mar 1, 2008; 19:508-515
]]> W. De Roock, H. Piessevaux, J. De Schutter, M. Janssens, G. De Hertogh, N. Personeni, B. Biesmans, J.-L. Van Laethem, M. Peeters, Y. Humblet, E. Van Cutsem, S. Tejpar 2008-03-01 Oxford University Press <![CDATA[Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines]]> http://annonc.oxfordjournals.org/cgi/content/short/7/1/95?rss=1&ssource=mfc Jan 1, 1996; 7:95-98
Short report]]> D. Machover, E. Diaz-Rubio, A. de Gramont, A. Schif, J.-J. Gastiaburu, S. Brienza, M. Itzhaki, G. Metzger, D. N''Daw, J. Vignoud, A. Abad, E. Francois, E. Gamelin, M. Marty, J. Sastre, J.-F. Seitz, M. Ychou 1996-01-01 Oxford University Press <![CDATA[Nutrition and cancer: Background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC)]]> http://annonc.oxfordjournals.org/cgi/content/short/3/10/783?rss=1&ssource=mfc Dec 1, 1992; 3:783-791
Special articles]]> E. Riboli 1992-12-01 Oxford University Press <![CDATA[Early restaging positron emission tomography with 18F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma]]> http://annonc.oxfordjournals.org/cgi/content/short/13/9/1356?rss=1&ssource=mfc Sep 1, 2002; 13:1356-1363
Hematologic malignancies]]> K. Spaepen, S. Stroobants, P. Dupont, P. Vandenberghe, J. Thomas, T. de Groot, J. Balzarini, C. De Wolf-Peeters, L. Mortelmans, G. Verhoef 2002-09-01 10.1093/annonc/mdf256 Oxford University Press <![CDATA[The World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November, 1997]]> http://annonc.oxfordjournals.org/cgi/content/short/10/12/1419?rss=1&ssource=mfc Dec 1, 1999; 10:1419-1432
]]> N. L. Harris, E. S. Jaffe, J. Diebold, G. Flandrin, H. K. Muller-Hermelink, J. Vardiman, T. A. Lister, C. D. Bloomfield 1999-12-01 Oxford University Press <![CDATA[Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth]]> http://annonc.oxfordjournals.org/cgi/content/short/13/1/65?rss=1&ssource=mfc Jan 19, 2002; 13:65-72
Breast cancer]]> N. Normanno, M. Campiglio, A. De Luca, G. Somenzi, M. Maiello, F. Ciardiello, L. Gianni, D. S. Salomon, S. Menard 2002-01-19 10.1093/annonc/mdf020 Oxford University Press <![CDATA[Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/8/2/163?rss=1&ssource=mfc Feb 1, 1997; 8:163-168
]]> B. Glimelius, K. Ekstrom, K. Hoffman, W. Graf, P.-O. Sjoden, U. Haglund, C. Svensson, L.-K. Enander, T. Linne, H. Sellsrom, R. Heuman 1997-02-01 Oxford University Press <![CDATA[Oxaliplatin: A review of preclinical and clinical studies]]> http://annonc.oxfordjournals.org/cgi/content/short/9/10/1053?rss=1&ssource=mfc Oct 1, 1998; 9:1053-1071
]]> E. Raymond, S. G. Chaney, A. Taamma, E. Cvitkovic 1998-10-01 Oxford University Press <![CDATA[First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin]]> http://annonc.oxfordjournals.org/cgi/content/short/13/4/566?rss=1&ssource=mfc Apr 1, 2002; 13:566-575
Gastrointestinal tumors]]> J. Cassidy, C. Twelves, E. Van Cutsem, P. Hoff, E. Bajetta, M. Boyer, R. Bugat, U. Burger, A. Garin, U. Graeven, J. McKendrick, J. Maroun, J. Marshall, B. Osterwalder, G. Perez-Manga, R. Rosso, P. Rougier, R. L. Schilsky 2002-04-01 10.1093/annonc/mdf089 Oxford University Press <![CDATA[Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma]]> http://annonc.oxfordjournals.org/cgi/content/short/9/9/995?rss=1&ssource=mfc Sep 1, 1998; 9:995-1001
]]> N. L. Berinstein, A. J. Grillo-Lopez, C. A. White, I. Bence-Bruckler, D. Maloney, M. Czuczman, D. Green, J. Rosenberg, P. McLaughlin, D. Shen 1998-09-01 Oxford University Press <![CDATA[Preoperative treatment of postmenopausal breast cancer patients with letrozole: A randomized double-blind multicenter study]]> http://annonc.oxfordjournals.org/cgi/content/short/12/11/1527?rss=1&ssource=mfc Nov 1, 2001; 12:1527-1532
]]> W. Eiermann, S. Paepke, J. Appfelstaedt, A. Llombart-Cussac, J. Eremin, J. Vinholes, L. Mauriac, M. Ellis, M. Lassus, H. A. Chaudri-Ross, M. Dugan, M. Borgs, V. Semiglazov 2001-11-01 Oxford University Press <![CDATA[Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/7/6/593?rss=1&ssource=mfc Aug 1, 1996; 7:593-600
]]> B. Glimelius, K. Hoffman, P.-O. Sjoden, G. Jacobsson, H. Sellstrom, L.-K. Enander, T. Linne, C. Svensson 1996-08-01 Oxford University Press <![CDATA[Malignant effusions contain lysophosphatidic acid (LPA)-like activity]]> http://annonc.oxfordjournals.org/cgi/content/short/9/4/437?rss=1&ssource=mfc Apr 1, 1998; 9:437-442
]]> A. M. Westermann, E. Havik, F. R. Postma, J. H. Beijnen, O. Dalesio, W. H. Moolenaar, S. Rodenhuis 1998-04-01 Oxford University Press <![CDATA[Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases]]> http://annonc.oxfordjournals.org/cgi/content/short/14/9/1399?rss=1&ssource=mfc Sep 1, 2003; 14:1399-1405
Breast cancer]]> J.-J. Body, I. J. Diel, M. R. Lichinitser, E. D. Kreuser, W. Dornoff, V. A. Gorbunova, M. Budde, B. Bergstrom 2003-09-01 10.1093/annonc/mdg367 Oxford University Press <![CDATA[Gastric MALT lymphoma: From concept to cure]]> http://annonc.oxfordjournals.org/cgi/content/short/10/6/637?rss=1&ssource=mfc Jun 1, 1999; 10:637-645
Special articles]]> P. G. Isaacson 1999-06-01 Oxford University Press <![CDATA[Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery]]> http://annonc.oxfordjournals.org/cgi/content/short/10/6/663?rss=1&ssource=mfc Jun 1, 1999; 10:663-669
]]> S. Giacchetti, M. Itzhaki, G. Gruia, R. Adam, R. Zidani, F. Kunstlinger, S. Brienza, E. Alafaci, F. Bertheault-Cvitkovic, C. Jasmin, M. Reynes, H. Bismuth, J. L. Misset, F Levi 1999-06-01 Oxford University Press <![CDATA[Clinical determinants of survival in patients with 5-fluorouracil- based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients]]> http://annonc.oxfordjournals.org/cgi/content/short/13/2/308?rss=1&ssource=mfc Feb 20, 2002; 13:308-317
Gastrointestinal tumors]]> C.-H. Kohne, D. Cunningham, F. Di Costanzo, B. Glimelius, G. Blijham, E. Aranda, W. Scheithauer, P. Rougier, M. Palmer, J. Wils, B. Baron, F. Pignatti, P. Schoffski, S. Micheel, H. Hecker 2002-02-20 10.1093/annonc/mdf034 Oxford University Press <![CDATA[Dietary glycemic load and colorectal cancer risk]]> http://annonc.oxfordjournals.org/cgi/content/short/12/2/173?rss=1&ssource=mfc Feb 1, 2001; 12:173-178
]]> S. Franceschi, L. Dal Masco, L. Augustin, E. Negri, M. Parpinel, P. Boyle, D. J. A. Jenkins, C. La Vecchia 2001-02-01 Oxford University Press <![CDATA[mTOR-targeted therapy of cancer with rapamycin derivatives]]> http://annonc.oxfordjournals.org/cgi/content/short/16/4/525?rss=1&ssource=mfc Apr 1, 2005; 16:525-537
Reviews]]> S. Vignot, S. Faivre, D. Aguirre, E. Raymond 2005-04-01 Oxford University Press <![CDATA[European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG)]]> http://annonc.oxfordjournals.org/cgi/content/short/15/9/1377?rss=1&ssource=mfc Sep 1, 2004; 15:1377-1399
Urogenital tumors]]> H. J. Schmoll, R. Souchon, S. Krege, P. Albers, J. Beyer, C. Kollmannsberger, S. D. Fossa, N. E. Skakkebaek, R. de Wit, K. Fizazi, J. P. Droz, G. Pizzocaro, G. Daugaard, P. H. M. de Mulder, A. Horwich, T. Oliver, R. Huddart, G. Rosti, L. Paz Ares, O. Pont, J. T. Hartmann, N. Aass, F. Algaba, M. Bamberg, I. Bodrogi, C. Bokemeyer, J. Classen, S. Clemm, S. Culine, M. de Wit, H. G. Derigs, K. P. Dieckmann, M. Flasshove, X. Garcia del Muro, A. Gerl, J. R. Germa-Lluch, M. Hartmann, A. Heidenreich, W. Hoeltl, J. Joffe, W. Jones, G. Kaiser, O. Klepp, S. Kliesch, L. Kisbenedek, K. U. Koehrmann, M. Kuczyk, M. P. Laguna, O. Leiva, V. Loy, M. D. Mason, G. M. Mead, R. P. Mueller, N. Nicolai, G. O. N. Oosterhof, T. Pottek, O. Rick, H. Schmidberger, F. Sedlmayer, W. Siegert, U. Studer, S. Tjulandin, H. von der Maase, P. Walz, S. Weinknecht, L. Weissbach, E. Winter, C. Wittekind 2004-09-01 10.1093/annonc/mdh301 Oxford University Press <![CDATA[Randomized, open-label, phase II trial of oral capecitabine (Xeloda(R)) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced/metastatic breast cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/12/9/1247?rss=1&ssource=mfc Sep 1, 2001; 12:1247-1254
]]> J. A. O''Shaughnessy, J. Blum, V. Moiseyenko, S. E. Jones, D. Miles, D. Bell, R. Rosso, L. Mauriac, B. Osterwalder, H.-U. Burger, S. Laws 2001-09-01 Oxford University Press <![CDATA[Letrozole, a new oral aromatase inhibitor: Randomised trial comparing 2.5 mg daily, 0.5 mg daily and aminoglutethimide in postmenopausal women with advanced breast cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/9/6/639?rss=1&ssource=mfc Jun 1, 1998; 9:639-645
]]> M. Gershanovich, H. A. Chaudri, D. Campos, H. Lurie, A. Bonaventura, M. Jeffrey, F. Buzzi, I. Bodrogi, H. Ludwig, P. Reichardt, N. O''Higgins, G. Romieu, P. Friederich, M. Lassus, Letrozole International Trial Group (AR/BC3) 1998-06-01 Oxford University Press <![CDATA[Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: A unicentre randomized trial with a 124-month median follow-up]]> http://annonc.oxfordjournals.org/cgi/content/short/10/1/47?rss=1&ssource=mfc Jan 1, 1999; 10:47-52
]]> L. Mauriac, G. MacGrogan, A. Avril, M. Durand, A. Floquet, M. Debled, J. M. Dilhuydy, F. Bonichon, Institut Bergonie Bordeaux Groupe Sein (IBBGS) 1999-01-01 Oxford University Press <![CDATA[The Hsp90 chaperone complex as a novel target for cancer therapy]]> http://annonc.oxfordjournals.org/cgi/content/short/14/8/1169?rss=1&ssource=mfc Aug 1, 2003; 14:1169-1176
Reviews]]> M. P. Goetz, D. O. Toft, M. M. Ames, C. Erlichman 2003-08-01 10.1093/annonc/mdg316 Oxford University Press <![CDATA[Phase I pharmacokinetic trial of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor gefitinib ('Iressa', ZD1839) in Japanese patients with solid malignant tumors]]> http://annonc.oxfordjournals.org/cgi/content/short/14/6/922?rss=1&ssource=mfc Jun 1, 2003; 14:922-930
Phase I and pharmacokinetics]]> K. Nakagawa, T. Tamura, S. Negoro, S. Kudoh, N. Yamamoto, N. Yamamoto, K. Takeda, H. Swaisland, I. Nakatani, M. Hirose, R.-P. Dong, M. Fukuoka 2003-06-01 10.1093/annonc/mdg250 Oxford University Press <![CDATA[t(11;18)(q21;q21) is the most common translocation in MALT lymphomas]]> http://annonc.oxfordjournals.org/cgi/content/short/8/10/979?rss=1&ssource=mfc Oct 1, 1997; 8:979-985
]]> I. A. Auer, R. D. Gascoyne, J. M. Conners, F. E. Cotter, T. C. Greiner, W. G. Sanger, D. E. Horsman 1997-10-01 Oxford University Press <![CDATA[Topoisomerase I inhibitors: Review and update]]> http://annonc.oxfordjournals.org/cgi/content/short/8/9/837?rss=1&ssource=mfc Aug 1, 1997; 8:837-855
]]> M. L. Rothenberg 1997-08-01 Oxford University Press <![CDATA[Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse]]> http://annonc.oxfordjournals.org/cgi/content/short/12/2/259?rss=1&ssource=mfc Feb 1, 2001; 12:259-266
]]> M. Brada, K. Hoang-Xuan, R. Rampling, P-Y. Dietrich, L. Y. Dirix, D. Macdonald, J. J. Heimans, B. A. Zonnenberg, J. M. Bravo-Marques, R. Henriksson, R. Stupp, N. Yue, J. Bruner, M. Dugan, S. Rao, S. Zaknoen 2001-02-01 Oxford University Press <![CDATA[Pegylated liposomal doxorubicin (doxil): Reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2]]> http://annonc.oxfordjournals.org/cgi/content/short/11/8/1029?rss=1&ssource=mfc Aug 1, 2000; 11:1029-1033
]]> T. Safra, F. Muggia, S. Jeffers, D. D. Tsao-Wei, S. Groshen, O. Lyass, R. Henderson, G. Berry, A. Gabizon 2000-08-01 Oxford University Press <![CDATA[FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma]]> http://annonc.oxfordjournals.org/cgi/content/short/16/9/1514?rss=1&ssource=mfc Sep 1, 2005; 16:1514-1523
Hematologic malignancies]]> N. G. Mikhaeel, M. Hutchings, P. A. Fields, M. J. O''Doherty, A. R. Timothy 2005-09-01 Oxford University Press <![CDATA[Epidermal growth factor receptor activating mutations in Spanish gefitinib-treated non-small-cell lung cancer patients]]> http://annonc.oxfordjournals.org/cgi/content/short/16/7/1081?rss=1&ssource=mfc Jul 1, 2005; 16:1081-1086
Lung cancer]]> H. Cortes-Funes, C. Gomez, R. Rosell, P. Valero, C. Garcia-Giron, A. Velasco, A. Izquierdo, P. Diz, C. Camps, D. Castellanos, V. Alberola, F. Cardenal, J. L. Gonzalez-Larriba, J. M. Vieitez, I. Maeztu, J. J. Sanchez, C. Queralt, C. Mayo, P. Mendez, T. Moran, M. Taron, On behalf of the Spanish Lung Cancer Group 2005-07-01 Oxford University Press <![CDATA[Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYXTM/Doxil(R)) versus conventional doxorubicin for first-line treatment of metastatic breast cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/15/3/440?rss=1&ssource=mfc Mar 1, 2004; 15:440-449
Breast cancer]]> M. E. R. O''Brien, N. Wigler, M. Inbar, R. Rosso, E. Grischke, A. Santoro, R. Catane, D. G. Kieback, P. Tomczak, S. P. Ackland, F. Orlandi, L. Mellars, L. Alland, C. Tendler 2004-03-01 10.1093/annonc/mdh097 Oxford University Press <![CDATA[Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project]]> http://annonc.oxfordjournals.org/cgi/content/short/13/1/140?rss=1&ssource=mfc Jan 19, 2002; 13:140-149
Hematologic malignancies]]> T. Rudiger, D. D. Weisenburger, J. R. Anderson, J. O. Armitage, J. Diebold, K. A. MacLennan, B. N. Nathwani, F. Ullrich, H. K. Muller-Hermelink 2002-01-19 10.1093/annonc/mdf033 Oxford University Press <![CDATA[Extended Rituximab (anti-CD20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma]]> http://annonc.oxfordjournals.org/cgi/content/short/10/6/655?rss=1&ssource=mfc Jun 1, 1999; 10:655-661
]]> L. D. Piro, C. A. White, A. J. Grillo-Lopez, N. Janakiraman, A. Saven, T. M. Beck, C. Varns, S. Shuey, M. Czuczman, J. W. Lynch, J. E. Kolit, V. Jain 1999-06-01 Oxford University Press <![CDATA[Oncologists politically tested]]> http://annonc.oxfordjournals.org/cgi/content/short/11/1/3?rss=1&ssource=mfc Jan 1, 2000; 11:3-3
News]]> 2000-01-01 Oxford University Press <![CDATA[Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/15/3/460?rss=1&ssource=mfc Mar 1, 2004; 15:460-466
Gastrointestinal tumors]]> L. Rubbia-Brandt, V. Audard, P. Sartoretti, A. D. Roth, C. Brezault, M. Le Charpentier, B. Dousset, P. Morel, O. Soubrane, S. Chaussade, G. Mentha, B. Terris 2004-03-01 10.1093/annonc/mdh095 Oxford University Press <![CDATA[Modified RECIST criteria for assessment of response in malignant pleural mesothelioma]]> http://annonc.oxfordjournals.org/cgi/content/short/15/2/257?rss=1&ssource=mfc Feb 1, 2004; 15:257-260
Lung cancer]]> M. J. Byrne, A. K. Nowak 2004-02-01 10.1093/annonc/mdh059 Oxford University Press <![CDATA[DNA methyltransferase inhibitors--state of the art]]> http://annonc.oxfordjournals.org/cgi/content/short/13/11/1699?rss=1&ssource=mfc Nov 1, 2002; 13:1699-1716
]]> J. Goffin, E. Eisenhauer 2002-11-01 10.1093/annonc/mdf314 Oxford University Press <![CDATA[Matrix metalloproteinase inhibition: A review of anti-tumour activity: Matrix metalloproteinase inhibition: A review of anti-tumour activity]]> http://annonc.oxfordjournals.org/cgi/content/short/6/10/967?rss=1&ssource=mfc Dec 1, 1995; 6:967-974
]]> P. D. Brown, R. Giavazzi 1995-12-01 Oxford University Press <![CDATA[A reduction in the requirements for mastectomy in a randomized trial of neoadjuvant chemoendocrine therapy in primary breast cancer]]> http://annonc.oxfordjournals.org/cgi/content/short/9/11/1179?rss=1&ssource=mfc Nov 1, 1998; 9:1179-1184
]]> A. Makris, T. J. Powles, S. E. Ashley, J. Chang, T. Hickish, V. A. Tidy, A. G. Nash, H. T. Ford 1998-11-01 Oxford University Press <![CDATA[In vitro antitumor activity of the novel marine agent, Ecteinascidin-743 (ET-743, NSC-648766) against human tumors explanted from patients]]> http://annonc.oxfordjournals.org/cgi/content/short/9/9/981?rss=1&ssource=mfc Sep 1, 1998; 9:981-987
]]> E. Izbicka, R. Lawrence, E. Raymond, G. Eckhardt, G. Faircloth, J. Jimeno, G. Clark, D. D. Von Hoff 1998-09-01 Oxford University Press <![CDATA[EUROCARE-3: survival of cancer patients diagnosed 1990-94--results and commentary]]> http://annonc.oxfordjournals.org/cgi/content/short/14/suppl_5/v61?rss=1&ssource=mfc Dec 1, 2003; 14:61-118
Abstracts]]> M. Sant, T. Aareleid, F. Berrino, M. Bielska Lasota, P. M. Carli, J. Faivre, P. Grosclaude, G. Hedelin, T. Matsuda, H. Moller, T. Moller, A. Verdecchia, R. Capocaccia, G. Gatta, A. Micheli, M. Santaquilani, P. Roazzi, D. Lisi, the EUROCARE Working Group 2003-12-01 10.1093/annonc/mdg754 Oxford University Press <![CDATA[Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial]]> http://annonc.oxfordjournals.org/cgi/content/short/13/10/1539?rss=1&ssource=mfc Oct 1, 2002; 13:1539-1549
Lung cancer]]> R. Rosell, U. Gatzemeier, D. C. Betticher, U. Keppler, H. N. Macha, R. Pirker, P. Berthet, J. L. Breau, P. Lianes, M. Nicholson, A. Ardizzoni, A. Chemaissani, J. Bogaerts, G. Gallant 2002-10-01 10.1093/annonc/mdf332 Oxford University Press <![CDATA[Treatment of hepatocellular carcinoma: A systematic review of randomized controlled trials]]> http://annonc.oxfordjournals.org/cgi/content/short/8/2/117?rss=1&ssource=mfc Feb 1, 1997; 8:117-136
]]> R. G. Simonetti, A. Liberati, C. Angiolini, L. Pagliaro 1997-02-01 Oxford University Press <![CDATA[Combined doxorubicin and paclitaxel in advanced breast cancer: Effective and cardiotoxic]]> http://annonc.oxfordjournals.org/cgi/content/short/7/7/687?rss=1&ssource=mfc Sep 1, 1996; 7:687-693
]]> J. Gehl, M. Boesgaard, T. Paaske, B. Vittrup Jensen, P. Dombernowsky 1996-09-01 Oxford University Press